Maria Fardis
Director · Obsidian Therapeutics, Inc.
Individual
- 2026
- Aug 5, 2026
- 2
Other insiders active in the same sector
No other insider has filed at Maria Fardis's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- RA CAPITAL MANAGEMENT, L.P. - $83.13M in VOR purchases and sales in the last 12 months
- Mark T. Bertolini - $82.60M in OSCR purchases and sales in the last 12 months
- Frank Torti - $82.04M in ROIV purchases and sales in the last 12 months
- Eric Venker - $80.09M in ROIV purchases and sales in the last 12 months
- ILLUMINA, INC. - $79.85M in GRAL purchases and sales in the last 12 months
- Darren M. Black - $77.56M in LFST purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Maria Fardis?
Maria Fardis is a corporate insider, tracked as Director of Obsidian Therapeutics, Inc. (OBX). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Maria Fardis submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.